The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive role of clinical benefit (CB) at 1st line on the outcome of subsequent lines in metastatic breast cancer (MBC) patients: analysis of a “real life” population.
 
Ornella Garrone
Honoraria - Celgene; Eisai; Novartis
 
Massimo Di Maio
Honoraria - Amgen; AstraZeneca; Bayer; Eisai; Lilly; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Lilly; Novartis
Speakers' Bureau - Boehringer Ingelheim; Novartis
 
Anna Maria Vandone
No Relationships to Disclose
 
Rodolfo Brizio
No Relationships to Disclose
 
Paola Vanella
No Relationships to Disclose
 
Emanuela Miraglio
No Relationships to Disclose
 
Alberto Comino
No Relationships to Disclose
 
Marco Carlo Merlano
Honoraria - Merck; Merck Sharp & Dohme
Consulting or Advisory Role - Merck; Merck Sharp & Dohme
Speakers' Bureau - Merck